Sentences with phrase «outcomes for at»

She leads research grants from NIDA, NIMH, and NICHD that focus on developmental pathways and intervention outcomes for at - risk youth and families.

Led by the Florida Association of Healthy Start Coalitions, Inc., the goal of the initiative is to improve health and developmental outcomes for at - risk children through evidence - based home visiting programs.

Each of the measures addresses an important factor that can lead to improved health and development outcomes for at - risk children through evidence - based home visiting.

The Maternal, Infant, and Early Childhood Home Visiting program (MIECHV) facilitates collaboration and partnership at the federal, state and community levels to improve health and development outcomes for at - risk children through evidence - based home visiting programs.

This evaluation, mandated by the Patient Protection and Affordable Care Act of 2010 (P.L. 111 - 148), is designed to build knowledge for policymakers and practitioners about the effectiveness of the MIECHV program in improving outcomes for at - risk children and families.

McDonough is a data manager who has worked on several projects at MDRC: Supporting Healthy Marriage (SHM) is an evaluation of marriage education programs targeting low - income, racially and ethnically diverse married couples; Head Start CARES (Classroom - based Approaches and Resources for Emotion and Social skill promotion) is a national evaluation of three evidence - based strategies to improve the social and emotional development of children in Head Start; the Mother and Infant Home Visiting Program Evaluation (MIHOPE) aims to build knowledge about the effectiveness of the new federally funded Maternal, Infant and Early Childhood Home - Visiting Program (MIECHV) in improving outcomes for at - risk children and families.

The Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program began in 2010 as a five - year, federal initiative to improve the health and development outcomes for at - risk children through evidence - based, voluntary home visiting programs provided to pregnant women and children birth to age 5.

Treatment outcomes for at - risk young children with behavior problems: Toward a new definition of success.

MIHOPE is designed to build knowledge for policymakers and practitioners about the effectiveness of the Maternal, Infant, and Early Childhood Home Visiting Program (MIECHV) in improving outcomes for at - risk children and families.

Authorized and funded at $ 1.5 billion for 5 years, the MIECHV represents a large investment in health and development outcomes for at - risk children through evidence - based home visiting programs.

Increasing the rate of voluntary paternity establishment, therefore, may improve child outcomes for this at - risk population.

Read about our home visiting programs and how they are improving outcomes for at - risk children and families in the 2009 Parents Too Soon / Doula Annual Report.

While individual shelters may consider allocating their own resources to improved medical and behavioral assessment for all animals in their care, it is important to acknowledge that transfer partnerships and community partnering are emerging as effective approaches to increasing live outcomes for all at - risk animals in shelters, particularly when an individual organization's resources are limited.

Grey Muzzle's piece will support the outreach initiative by funding the cost of veterinary care for senior dogs in the program and we hope that, together, we can strengthen and expand the collective reach, creating positive outcomes for at - risk pets while promoting this emotional bond that is so critical to the health and wellness of these vulnerable populations.

The Animal Services Office is dedicated to sustaining Austin's No Kill commitment of achieving live outcomes for at least 90 percent of the companion animals entering the center annually.

Her research focuses on evaluating the extent to which public policies and programs improve outcomes for at - risk students.

And the school board and the city began to think of ways they might run both entities more efficiently and improve outcomes for at - risk students.

These interventions should be research - based and proven (through research reported in scientific, peer - reviewed journals) to decrease the risk of poor learning outcomes for at - risk students.

Too often educational outcomes for at - risk youth are tertiary considerations after safety and residency.

Summary: This article reports on anew Princeton study examined the long - term effects of a 20 - year - old program known as Fast Track, one of the earliest and largest programs designed to improve life outcomes for at - risk students by teaching psychosocial skills.

But how can we convince policymakers to increase investment in early care and education and improve life outcomes for at - risk children?

A large body of evidence supports the notion that charter schools will deliver better outcomes for at - risk students.

In the higher education arena, this issue highlights two strategies that promise to improve outcomes for at - risk students.

In the 1990s, Fast Track was one of the earliest, and largest, programs designed to improve life outcomes for at - risk students.

«National school - based mental health intervention improves outcomes for at - risk students: Participation in Chilean Skills for Life program reduced mental health symptoms, improved school attendance and promotion.»

We now have a treatment that can significantly improve outcomes for these at risk babies.»

The researchers urge the education community to consider the role of afterschool classrooms and instructors in promoting supportive interactions and advancing academic outcomes for at - risk youth during this important transition to adolescence.

This evaluation, mandated by the Patient Protection and Affordable Care Act of 2010 (P.L. 111 - 148), is designed to build knowledge for policymakers and practitioners about the effectiveness of the MIECHV program in improving outcomes for at - risk children and families.

Supporting high - fidelity implementation of evidence - based home visiting programs has the potential to improve outcomes for at - risk children and families.

Our skilled team of attorneys will work with insurance adjusters on your behalf to reach a fair settlement agreement or fight to obtain the best possible outcome for you at trial.

Not sure of the outcome for him at the moment.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

The move by these hugely successful companies is, in fact, only the latest in a slew of corporate actions aimed at reconfiguring healthcare in the U.S. — a system where outcomes, for the most part, remain woefully disconnected from costs, and where those costs continue to soar without the mooring of reason.

Although the FiveThirtyEight founder doesn't mention it (at least not yet), the media's desire for false equivalence or false balance likely played a role in the election's outcome as well.

A 2012 study from the Centre for Retirement Research at Boston College in the United States found that the greater number of older persons employed led to better outcomes for the young, including reduced unemployment and a higher wage.

Because observational studies look at groups of people and their behavior over time, it's hard to say for sure that other conflicting factors aren't influencing the outcomes they examine.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

But no matter the outcome, critics of the agency have begun laying the groundwork for the Trumpadministration to make dramatic changes to the institution at the heart of President Barack Obama's overhaul of the financial system.

For instance, we were once in a proceeding in which the judge made a ruling on evidence presented at trial by opposing counsel that was going to fundamentally change the outcome of the case.

LONDON, May 2 - The dollar consolidated gains on Friday after hitting a 3 - 1 / 2 month high in the previous session as investors waited for the outcome of a U.S. «Despite the moves we have seen in the dollar in recent days, financial conditions haven't really tightened noticeably but that may change if the rally continues,» said Manuel Oliveri, an FX strategist at Credit...

Additionally, the study recommended the military pre-screen all troops prior to their deployment to Guantanamo to identify pre-existing behavioral health conditions in order to prevent «those at increased risk for negative behavioral health outcomes from being assigned» to the base.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

They're not trained for, nor are they typically very good at, ensuring optimal business outcomes.

Competition, as Kilduff defines it, is any situation in which the goals or outcomes of the actors involved are opposed to one another, so a gain for one player inherently comes at a loss for the other.

If policymakers, however, resolve to have no government involvement at all, the bond market will price it out for you, but the likely outcome is a residential mortgage market that is smaller, more expensive, and less liquid.

«If you look at the outcome of the MBAs, for most of us it means a good job,» Rai tells boot campers on their visit to the Henkel office.

According to Whoriskey, ``... executive compensation at the nation's largest firms has roughly quadrupled in real terms since the 1970s, even as pay for 90 percent of America has stalled...» Setting aside imprecision of language, that suggests a significant disparity — not disparity of outcomes (which are a given, here) but disparity of rate of improvement.

Aaron A. Dhir, of York University's Osgoode Hall Law School, concluded having at least three women on a board has significant positive outcomes for a company.

A positive outcome from the study would mean a need for increased infrastructure at the port, including shipping conveyors and a storage shed.

Students who complete their degrees as well as master's degree recipients at for - profit schools tend to have better outcomes and positive earning effects post-graduation.